Skip to main content
OpenTrials
Completed

NCT Number: NCT03360903

A Study to Determine if Caffeine Accelerates Emergence From Propofol Anesthesia

At present clinicians have no way to reverse anesthesia. Patients wake when their bodies clear the anesthetic. Most people wake quickly, but some do not. All patients have memory and other cognitive problems after waking from anesthesia. In studies on animals, the investigators observed that caffeine caused rats to wake much more rapidly from propofol anesthesia. This was true for all the animals tested. The investigators would like to see if this holds true in humans. Will caffeine accelerate waking from anesthesia? Will it reverse the cognitive deficits associated with anesthesia, after waking?

The propose investigators carrying out a modest trial with 8 test subjects. Each volunteer will be anesthetized twice. Each volunteer will be anesthetized one time and receive an infusion of saline (placebo control), without the aid of any other drugs and the other time the volunteer will receive an infusion of a relatively low dose of caffeine. The order of saline versus caffeine will be randomized and the study will be done in a double blind manner. We will determine whether emergence from propofol anesthesia will be significantly accelerated by the caffeine infusion. And whether any adverse events are observed.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Anesthesia

Age range

25 year–40 year

Sex eligibility

Male

Study type

Interventional

Phase

Phase 4

Primary location

The University of Chicago

Chicago, Illinois, 60637, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 25-40.
  • Male.
  • Normal healthy subject without systematic diseases or conditions.
  • Metabolic Equivalents of Functional Capacity >= 5.
  • Low risk for Obstructive Sleep Apnea (OSA) based on the screening test (STOP-bang score established by American Society of Sleep Apnea): Yes to > 3 items- high risk of OSA
  • No History of Arrhythmia (Baseline EKG will be obtained during the history and physical session), seizure, liver and kidney diseases.
  • BMI < 30 kg/m2.
  • No history of prior difficulty with anesthesia.
  • No personal or family history of malignant hyperthermia.
  • No history of any mental illness.
  • No history of drugs or alcohol abuse (urine drug screens required).
  • Subjects capable of giving consent.
  • Living less than 30 miles away from University of Chicago.
  • No history of seizure disorders.
  • No history of head trauma.

Exclusion criteria

  • Age <25 or >40.
  • Female.
  • ASA physical status > 1 (normal healthy subject without systematic diseases or conditions)
  • Metabolic Equivalents of Functional Capacity (METs) < 5.
  • High risks for Obstructive Sleep Apnea (OSA) based on the screening test (STOP-bang score established by American Society of Sleep Apnea): Yes to > 3 items- high risk of OSA
  • History Arrhythmia (Baseline EKG will be obtained during the history and physical session), seizure, liver and kidney diseases
  • BMI>30 kg/m2.
  • Prior difficulty with anesthesia.
  • Personal or family history of malignant hyperthermia.
  • History of any mental illness.
  • History of drugs or alcohol abuse (urine drug screens required)
  • Subjects not capable of giving consent
  • Living more than 30 miles away from University of Chicago.
  • History of seizure disorders.
  • History of head trauma.

Treatment and study plan

Placebo

Drug

Anesthetized volunteers will be allowed to wake after injection of saline (placebo control).

Other Names:

  • Saline

Caffeine

Drug

Anesthetized volunteers will be allowed to wake after injection of caffeine (15 mg/ kg).

Other Names:

  • Caffeine citrate

Primary outcomes

  1. Waking Time - Time Between Terminating Anesthesia and Subject Opening Eyes.

    Time frame: 15 minutes

    The goal of the study is to determine whether caffeine speeds emergence from anesthesia. The time between terminating delivery of anesthetic and the subject opening their eyes will be measured. The time to "emerge" from anesthesia will be defined as the time between terminating the anesthesia and the test subject opening their eyes.

Secondary outcomes

  1. Cognitive Test1 - Visual Analog Scale

    Time frame: Up to 120 minutes after terminating anesthesia.

    Normally patients receiving anesthesia exhibit significant cognitive problems for hours after anesthesia is terminated. The goal is to determine whether caffeine helps ameliorate the cognitive issues. Fifteen minutes after terminating anesthesia each subject will be asked to complete a series of psychomotor tests, if they are able. Otherwise the testing started at 30 minutes. The tests will be repeated every 15 minutes. The first test, a visual analog scale (VAS) test consisted of two 100-mm lines, each labelled with of "feel good" or "feel bad" displayed on a computer screen. Test subjects will be asked to rate how they currently felt by placing a cursor on each of the line (0=not at all, 100=extremely). The test will be repeated every 15 minutes.

  2. Cognitive Test2 - Sternberg Test of Memory

    Time frame: Up to 120 minutes after terminating anesthesia.

    Normally patients receiving anesthesia exhibit significant cognitive problems for hours after anesthesia is terminated. The goal is to determine whether caffeine helps ameliorate the cognitive issues. The test will be applied at 15 minutes following anesthesia, if the subject is awake and then repeated every 15 minutes. In the Sternberg Test of Memory (STM) participants are asked to memorize a string of numbers. Afterwards, a computer will flash a series of random numbers on the screen and the participant is asked whether the number on the computer screen are part of the earlier string or not. In three rounds, participants are given a string of 2, then 4, then 6 numbers. The latency until the subject answers the question is also monitored.

  3. Cognitive Test3 - Divided Attention Task

    Time frame: Up to 120 minutes after terminating anesthesia.

    Normally patients receiving anesthesia exhibit significant cognitive problems for hours after anesthesia is terminated. The goal is to determine whether caffeine helps ameliorate the cognitive issues. The test is first applied at 15 minutes following anesthesia, if the subject is awake and then repeated every 15 minutes. In the Divided Attention Task (DAT), participants are asked to fly an airplane over the center of a winding road with a joystick and simultaneously press a button whenever targets randomly flash on the screen. The computer program tracks the root mean squared (RMS) deviation of the plane from the center of the road and the latency for pressing the trigger when the target appears.

  4. Bispectral Index

    Time frame: Up to 120 minutes after terminating anesthesia.

    A bispectral index (BIS) measurement system is employed to measure depth of anesthesia. In particular, we wish to determine whether BIS exhibits more rapid recovery after caffeine compared to control.

  5. Mean Arterial Blood Pressure

    Time frame: Up to 120 minutes after terminating anesthesia.

    This measurement is made in order to determine whether caffeine alters blood pressure in a deleterious manner.

  6. Heart Rate

    Time frame: Up to 120 minutes after terminating anesthesia.

    This measurement is made in order to determine whether caffeine alters heart rate in a deleterious manner.

Sponsors and collaborators

Lead sponsor

University of Chicago

Other

Collaborators

  • National Institute of General Medical Sciences (NIGMS)
  • National Institutes of Health (NIH)

Registry information

Official study title

A Randomized, Double-Blinded, Placebo-Controlled Study to Determine if Caffeine Citrate Accelerates Emergence From Anesthesia

Important dates

Study start
2018
Primary completion
2018
Study completion
2019
First posted
Dec 4, 2017
Registry last updated
Nov 18, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.